Capricor Therapeutics Inc(CAPR)

盘后12.930.12+0.94%18:35 EST

12.81-0.77-5.70%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Capricor Therapeutics Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.capricor.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的疗法，用于治疗Duchenne肌营养不良症（“DMD”），这是一种罕见的导致肌肉退化和过早死亡的肌营养不良症，以及具有高度未满足的医疗需求的疾病。
- 03-04
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-05
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 01-02
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-15
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-08
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-11-07
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-10-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-10-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-10-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-24
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-24
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-09-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report